← Leaderboards
Daniel Higginson
Sloan-Kettering Inst Can Research
$2,721,108
Attributed
$2,721,108
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,721,108 · 4
By mechanism
R33$1,322,190 · 1
R01$736,168 · 1
R21$486,750 · 1
R03$176,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Jason S Lewis$26,024,327
- Yelena Y Janjigian$1,716,445
- Alexander Drilon$4,847,187
- Sarat Chandarlapaty$10,852,142
- Michael H. A. Roehrl$6,530,724
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsMalignant NeoplasmsTumorInvestigationAffectDesignCancer TherapyResponseGrantIn VivoIntestinesInhibitorCell LineIn VitroKinase InhibitorGenomic LocusCarcinogenesisGenomicsDose LimitingBasic ScienceAntibody-Drug ConjugatesFda ApprovedEfficacy EvaluationDetection
Grant awards (6)
Antigen-specific radiosensitization$736,168
R01 · FY2025 · CA · contact PI
Recombinase polymerase amplification to enable same-cell, DNA/RNA multi-omic single cell sequencing$221,250
R21 · FY2025 · GM · contact PI
PSMA ligand radiosensitizers to improve the therapeutic index of external beam radiotherapy for prostate cancer$88,000
R03 · FY2025 · CA · contact PI
Recombinase polymerase amplification to enable same-cell, DNA/RNA multi-omic single cell sequencing$265,500
R21 · FY2024 · GM · contact PI
PSMA ligand radiosensitizers to improve the therapeutic index of external beam radiotherapy for prostate cancer$88,000
R03 · FY2024 · CA · contact PI
Comprehensive breakpoint analyses for simultaneous quantification of all DNA double strand break repair pathways$1,322,190
R33 · FY2020 · CA · contact PI